On the possible role of brain protein synthesis in functional barbiturate tolerance

Robert Hitzemann, Horace H. Loh

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Pentobarbital pellet implantation increased more than 200% the ED50 dose of pentobarbital required to induce loss of the righting reflex within 2 min of i.p. injection and increased the onset of barbital-induced sleep. Both tests of functional barbiturate tolerance were blocked by the intraventricular injection of cycloheximide. The effects of acute (45 mg/kg i.p.) and chronic (pellet implantation) pentobarbital treatment on the incorporation of 3H-lysine into the protein of various subcellular fractions of the cortex and subcortex were studied. In the subcortex, chronic pentobarbital treatment significantly stimulated protein synthesis 40-50% in the microsomal, soluble and mitochondrial fractions. Both acute and chronic pentobarbital treatments significantly increased (3H-lys)-protein accumulation in a fraction of synaptic plasma membranes derived from a population of nerve ending particles (NEP) enriched in γ-aminobutyric acid (GABA). The possible significance of these data to pentobarbital tolerance and dependence development is discussed.

Original languageEnglish (US)
Pages (from-to)163-173
Number of pages11
JournalEuropean Journal of Pharmacology
Volume40
Issue number1
DOIs
StatePublished - 1976
Externally publishedYes

Fingerprint

Pentobarbital
Brain
Proteins
Barbital
Righting Reflex
Intraventricular Injections
Aminobutyrates
Synaptic Membranes
Subcellular Fractions
Nerve Endings
Cycloheximide
gamma-Aminobutyric Acid
Lysine
barbituric acid
Sleep
Therapeutics
Cell Membrane
Injections
Population

Keywords

  • Cycloheximide
  • Pentobarbital
  • Protein synthesis
  • Synaptic plasma membrane
  • Tolerance

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience
  • Pharmacology

Cite this

On the possible role of brain protein synthesis in functional barbiturate tolerance. / Hitzemann, Robert; Loh, Horace H.

In: European Journal of Pharmacology, Vol. 40, No. 1, 1976, p. 163-173.

Research output: Contribution to journalArticle

@article{61c3592feb334eeab28876da8f7bb8b4,
title = "On the possible role of brain protein synthesis in functional barbiturate tolerance",
abstract = "Pentobarbital pellet implantation increased more than 200{\%} the ED50 dose of pentobarbital required to induce loss of the righting reflex within 2 min of i.p. injection and increased the onset of barbital-induced sleep. Both tests of functional barbiturate tolerance were blocked by the intraventricular injection of cycloheximide. The effects of acute (45 mg/kg i.p.) and chronic (pellet implantation) pentobarbital treatment on the incorporation of 3H-lysine into the protein of various subcellular fractions of the cortex and subcortex were studied. In the subcortex, chronic pentobarbital treatment significantly stimulated protein synthesis 40-50{\%} in the microsomal, soluble and mitochondrial fractions. Both acute and chronic pentobarbital treatments significantly increased (3H-lys)-protein accumulation in a fraction of synaptic plasma membranes derived from a population of nerve ending particles (NEP) enriched in γ-aminobutyric acid (GABA). The possible significance of these data to pentobarbital tolerance and dependence development is discussed.",
keywords = "Cycloheximide, Pentobarbital, Protein synthesis, Synaptic plasma membrane, Tolerance",
author = "Robert Hitzemann and Loh, {Horace H.}",
year = "1976",
doi = "10.1016/0014-2999(76)90366-6",
language = "English (US)",
volume = "40",
pages = "163--173",
journal = "European Journal of Pharmacology",
issn = "0014-2999",
publisher = "Elsevier",
number = "1",

}

TY - JOUR

T1 - On the possible role of brain protein synthesis in functional barbiturate tolerance

AU - Hitzemann, Robert

AU - Loh, Horace H.

PY - 1976

Y1 - 1976

N2 - Pentobarbital pellet implantation increased more than 200% the ED50 dose of pentobarbital required to induce loss of the righting reflex within 2 min of i.p. injection and increased the onset of barbital-induced sleep. Both tests of functional barbiturate tolerance were blocked by the intraventricular injection of cycloheximide. The effects of acute (45 mg/kg i.p.) and chronic (pellet implantation) pentobarbital treatment on the incorporation of 3H-lysine into the protein of various subcellular fractions of the cortex and subcortex were studied. In the subcortex, chronic pentobarbital treatment significantly stimulated protein synthesis 40-50% in the microsomal, soluble and mitochondrial fractions. Both acute and chronic pentobarbital treatments significantly increased (3H-lys)-protein accumulation in a fraction of synaptic plasma membranes derived from a population of nerve ending particles (NEP) enriched in γ-aminobutyric acid (GABA). The possible significance of these data to pentobarbital tolerance and dependence development is discussed.

AB - Pentobarbital pellet implantation increased more than 200% the ED50 dose of pentobarbital required to induce loss of the righting reflex within 2 min of i.p. injection and increased the onset of barbital-induced sleep. Both tests of functional barbiturate tolerance were blocked by the intraventricular injection of cycloheximide. The effects of acute (45 mg/kg i.p.) and chronic (pellet implantation) pentobarbital treatment on the incorporation of 3H-lysine into the protein of various subcellular fractions of the cortex and subcortex were studied. In the subcortex, chronic pentobarbital treatment significantly stimulated protein synthesis 40-50% in the microsomal, soluble and mitochondrial fractions. Both acute and chronic pentobarbital treatments significantly increased (3H-lys)-protein accumulation in a fraction of synaptic plasma membranes derived from a population of nerve ending particles (NEP) enriched in γ-aminobutyric acid (GABA). The possible significance of these data to pentobarbital tolerance and dependence development is discussed.

KW - Cycloheximide

KW - Pentobarbital

KW - Protein synthesis

KW - Synaptic plasma membrane

KW - Tolerance

UR - http://www.scopus.com/inward/record.url?scp=0017099665&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0017099665&partnerID=8YFLogxK

U2 - 10.1016/0014-2999(76)90366-6

DO - 10.1016/0014-2999(76)90366-6

M3 - Article

C2 - 991923

AN - SCOPUS:0017099665

VL - 40

SP - 163

EP - 173

JO - European Journal of Pharmacology

JF - European Journal of Pharmacology

SN - 0014-2999

IS - 1

ER -